4//SEC Filing
Sjuts Dustin S 4
Accession 0001479290-23-000013
CIK 0001479290other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 9:37 PM ET
Size
5.4 KB
Accession
0001479290-23-000013
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-01-31+43,255→ 43,255 totalExercise: $34.68Exp: 2033-01-30→ Common Stock (43,255 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 31, 2023, subject to Mr. Sjuts' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 9:37 PM ET
- Size
- 5.4 KB